Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma

被引：3

作者：

Maura, Francesco ^{[1
]}

Rajanna, Arjun Raj ^{[1
]}

Derkach, Andriy ^{[2
]}

Ziccheddu, Bachisio ^{[3
]}

Weinhold, Niels ^{[4
]}

Maclachlan, Kylee H. ^{[5
]}

Diamond, Benjamin ^{[1
]}

Davies, Faith E. ^{[6
]}

Boyle, Eileen ^{[6
]}

Walker, Brian A. ^{[7
]}

Poos, Alexandra M. ^{[4
]}

Hultcrantz, Malin ^{[5
]}

Silva, Ariosto Siqueira ^{[8
]}

Hampton, Oliver ^{[9
]}

Teer, Jamie ^{[8
]}

Bolli, Niccolo ^{[10
,11
]}

Jackson, Graham ^{[12
]}

Kaiser, Martin F. ^{[13
]}

Pawlyn, Charlotte ^{[13
]}

Cook, Gordon ^{[14
]}

Verducci, Dennis ^{[1
]}

Kazandjian, Dickran ^{[1
]}

van Rhee, Frits ^{[15
]}

Usmani, Saad ^{[16
]}

Shain, Ken H. ^{[8
]}

Raab, Marc S. ^{[4
]}

Morgan, Gareth J. ^{[6
]}

Landgren, Ola ^{[3
]}

机构：

[1] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Div, Miami, FL USA

[2] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA

[3] Univ Miami, Sylvester Comprehens Canc Ctr, Myeloma Serv, Miami, FL USA

[4] Univ Hosp Heidelberg, Dept Internal Med 5, Multiple Myeloma Res Grp, Heidelberg, Germany

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10021 USA

[6] NYU Langone, Perlmutter Canc Ctr, New York, NY USA

[7] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Div Hematol Oncol, Indianapolis, IN 46204 USA

[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

[9] M2GEN, Tampa, FL USA

[10] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol Unit, Milan, Italy

[11] Univ Milan, Milan, Italy

[12] Dept Haematol, NCCC Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England

[13] Inst Canc Res, London, England

[14] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England

[15] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR 72205 USA

[16] Mem Sloan Kettering Canc Ctr, Myeloma Serv, New York, NY USA

来源：

BLOOD | 2022年 / 140卷

关键词：

D O I：

10.1182/blood-2022-160215

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1561 / 1563

页数：3

共 50 条

[31] Risk of Early Mortality in Patients With Newly Diagnosed Multiple Myeloma
Hsu, Pei
Lin, Ting-Wei
Gau, Jyh-Pyng
Yu, Yuan-Bin
Hsiao, Liang-Tsai
Tzeng, Cheng-Hwai
Chen, Po-Min
Chiou, Tzeon-Jye
Liu, Jin-Hwang
Liu, Yao-Chung
Liu, Chia-Jen
MEDICINE, 2015, 94 (50)
[32] Risk of Early Mortality in Patients with Newly Diagnosed Multiple Myeloma
Liu, Chia-Jen
Hsu, Pei
Lin, Ting-Wei
Gau, Jyh-Pyng
Hsiao, Liang-Tsai
Tzeng, Cheng-Hwai
Chen, Po-Min
Yu, Yuan-Bin
Chiou, Tzeon-Jye
Liu, Yao-Chung
Liu, Jing-Hwang
BLOOD, 2015, 126 (23)
[33] CD20 expression: A risk stratification factor for newly diagnosed multiple myeloma with t(11;14)
Jian, Yuan
Zhang, Zhiyao
Zhou, Huixing
Yang, Guangzhong
Geng, Chuanying
Wang, Huijuan
Gao, Wen
Chen, Wenming
FRONTIERS IN ONCOLOGY, 2022, 12
[34] Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
Kapoor, Prashant
Fonseca, Rafael
Rajkumar, S. Vincent
Sinha, Shirshendu
Gertz, Morie A.
Stewart, A. Keith
Bergsagel, P. Leif
Lacy, Martha Q.
Dingli, David D.
Ketterling, Rhett P.
Buadi, Francis
Kyle, Robert A.
Witzig, Thomas E.
Greipp, Philip R.
Dispenzieri, Angela
Kumar, Shaji
MAYO CLINIC PROCEEDINGS, 2010, 85 (06) : 532 - 537
[35] Treatment of newly diagnosed myeloma
A Palumbo
S V Rajkumar
Leukemia, 2009, 23 : 449 - 456
[36] Treatment of newly diagnosed myeloma
Palumbo, A.
Rajkumar, S. V.
LEUKEMIA, 2009, 23 (03) : 449 - 456
[37] The Role of Maintenance Therapy in the Treatment of Newly Diagnosed Multiple Myeloma
Gahvari, Zhubin
Callander, Natalie
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S53 - S56
[38] Continuous treatment with new agents for newly diagnosed multiple myeloma
Zou, Yandun
Sheng, Zhixin
Lu, Hongkai
Yu, Jinming
ANTI-CANCER DRUGS, 2013, 24 (05) : 527 - 533
[39] Treatment of newly diagnosed multiple myeloma: advances in current therapy
Kumar, Shaji
MEDICAL ONCOLOGY, 2010, 27 : 14 - 24
[40] Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
Ola Landgren
Pieter Sonneveld
Andrzej Jakubowiak
Mohamad Mohty
Karim S. Iskander
Khalid Mezzi
David S. Siegel
Leukemia, 2019, 33 : 2127 - 2143

← 1 2 3 4 5 →